These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 57447)

  • 21. Parathyroid hormone: a double-edged sword for bone metabolism.
    Qin L; Raggatt LJ; Partridge NC
    Trends Endocrinol Metab; 2004 Mar; 15(2):60-5. PubMed ID: 15036251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis.
    Horwitz MJ; Tedesco MB; Gundberg C; Garcia-Ocana A; Stewart AF
    J Clin Endocrinol Metab; 2003 Feb; 88(2):569-75. PubMed ID: 12574182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone turnover-sex hormone-parathyroid hormone interrelationships in postmenopausal osteoporosis.
    Riggs B; Jowsey J; Kelly PJ; Arnaud CD
    Boll Soc Ital Biol Sper; 1973 Jul; 49(12):732-7. PubMed ID: 4364781
    [No Abstract]   [Full Text] [Related]  

  • 24. The aged rat model of ovarian hormone deficiency bone loss.
    Kalu DN; Liu CC; Hardin RR; Hollis BW
    Endocrinology; 1989 Jan; 124(1):7-16. PubMed ID: 2909382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Regulation of in vitro metabolism of human spongiosa by parathyroid hormone and calcitonin].
    Keck E; Schärtl A; Krüskemper HL
    Z Orthop Ihre Grenzgeb; 1986; 124(3):344-9. PubMed ID: 3751249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
    Cosman F; Nieves J; Woelfert L; Formica C; Gordon S; Shen V; Lindsay R
    J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
    Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
    Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consistency of bone turnover marker and calcium responses to parathyroid hormone (1-84) therapy in postmenopausal osteoporosis.
    Schafer AL; Palermo L; Bauer DC; Bilezikian JP; Sellmeyer DE; Black DM
    J Clin Densitom; 2011; 14(1):68-73. PubMed ID: 21095149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis.
    Jowsey J; Riggs BL; Goldsmith RS; Kelly PJ; Arnaud CD
    J Clin Endocrinol Metab; 1971 Nov; 33(5):752-8. PubMed ID: 4942159
    [No Abstract]   [Full Text] [Related]  

  • 30. Parathyroid hormone in the treatment of osteoporosis.
    Fujita T
    BioDrugs; 2001; 15(11):721-8. PubMed ID: 11707147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of PTH on bone structural properties].
    Ito M
    Clin Calcium; 2012 Mar; 22(3):335-41. PubMed ID: 22370300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The rhPTH (1-34), but not elcatonin, increases bone anabolic efficacy in postmenopausal women with osteoporosis.
    Zhang L; Yang M; Liu D; Guo C; Li L; Yang G
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):361-6. PubMed ID: 22639400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New approaches to the problems of osteoporosis.
    Nordin BE; Need AG; Morris HA; Horowitz M
    Clin Orthop Relat Res; 1985 Nov; (200):181-97. PubMed ID: 3905110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Osteoporosis in thyroid disease].
    Mitsuma T
    Nihon Rinsho; 1990 Dec; 48(12):2898-903. PubMed ID: 2086852
    [No Abstract]   [Full Text] [Related]  

  • 36. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency.
    Finkelstein JS; Klibanski A; Schaefer EH; Hornstein MD; Schiff I; Neer RM
    N Engl J Med; 1994 Dec; 331(24):1618-23. PubMed ID: 7969342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The turnover time of calcium in the exchangeable pools of bone in man and the long-term effect of a parathyroid hormone fragment.
    Reeve J
    Clin Endocrinol (Oxf); 1978 Jun; 8(6):445-55. PubMed ID: 668151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Morphological analysis of bone dynamics and metabolic bone disease. Effects of parathyroid hormone on bone tissue].
    Miyakoshi N
    Clin Calcium; 2011 Apr; 21(4):575-81. PubMed ID: 21447925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis.
    Shiraki M; Fukuchi M; Kiriyama T; Okamoto S; Ueno T; Sakamoto H; Nagai T
    J Bone Miner Metab; 2004; 22(4):352-9. PubMed ID: 15221494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.